Clinical Trials Browser

Phase NA × Recruiting × HER2-positive Breast Cancer × Clear all

NCT07281001 2025-12-15

Traderrus

Phase NA Recruiting

HER2-positive Breast Cancer

NCT06123988 2025-08-06

FastER

Phase NA Recruiting

HER2-positive Breast Cancer

NCT06330012 2024-03-26

The Resistance Mechanism of Trastuzumab Deruxtexan in HER2 Positive Breast Cancer Patients.

Phase NA Recruiting

HER2-positive Breast Cancer

NCT04281641 2020-05-04

PHC-BC

Phase NA Recruiting

HER2-positive Breast Cancer